Short-term clinical efficacy and safety of unilateral biportal endoscopic transforaminal lumbar interbody fusion versus minimally invasive transforaminal lumbar interbody fusion in the treatment of lumbar degenerative diseases: a systematic review and meta-analysis

医学 外科 腰椎 纳入和排除标准 荟萃分析 背痛 置信区间 脊柱融合术 骨科手术 内科学 病理 替代医学
作者
Hao Han,Yifan Song,Yiming Li,Hengcai Zhou,Yu-Fei Fu,Jie Li
出处
期刊:Journal of Orthopaedic Surgery and Research [BioMed Central]
卷期号:18 (1): 656-656 被引量:30
标识
DOI:10.1186/s13018-023-04138-0
摘要

BACKGROUND: The aim of this study was to comprehensively evaluate the short-term clinical efficacy and safety of unilateral biportal endoscopic transforaminal lumbar interbody fusion (UBE-TLIF) versus minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF) for the treatment of lumbar degenerative diseases by meta-analysis. METHODS: A computer-based search of PubMed, Embase, Web of Science, Cochrane Database, China National Knowledge Infrastructure (CNKI), Wanfang Database, and Chinese Science and Technology Journal Database (VIP) was conducted from the inception of the each database to April 2023. The searched literature was then screened according to strict inclusion and exclusion criteria. The critical data were extracted and analyzed using Review Manager software5.4.1. Pooled effects were calculated on the basis of data attributes by mean difference (MD) or odds ratio (OR) with 95% confidence interval (CI). The Newcastle-Ottawa Scale was used to assess the quality of the studies. RESULTS: A total of 13 studies and 949 patients met the inclusion criteria for this meta-analysis, 445 in the UBE-LIF group and 504 in the MIS-TLIF group. UBE-TLIF was superior to MIS-TLIF in terms of intraoperative blood flow, postoperative drainage flow, duration of hospital stay, VAS score for low back pain and ODI score, but the operative time was longer than MIS-TLIF group. There were no significant differences between the two groups in terms of total complication rate, modified Macnab grading criteria, fusion rate, VAS score of leg pain, lumbar lordosis, intervertebral disk height. CONCLUSION: Both UBE-TLIF and MIS-TLIF are effective surgical modalities for the treatment of degenerative lumbar spine diseases. They have similar treatment outcomes, but UBE-TLIF has the advantages of less intraoperative blood loss, shorter postoperative hospital stay, and faster recovery. TRIAL REGISTRATION: This study has been registered at INPLASY.COM (No. INPLASY202320087).

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
hehe完成签到,获得积分10
刚刚
vnewgnl的应助被drizzle采纳,获得10
1秒前
HJJHJH发布了新的文献求助10
4秒前
Nole的应助被苦瓜采纳,获得10
5秒前
上官若男的应助被阔达的冰露采纳,获得10
5秒前
6秒前
桐桐的应助被Vater采纳,获得10
7秒前
可爱的函函的应助被HJJHJH采纳,获得10
8秒前
8秒前
dxw完成签到,获得积分10
8秒前
9秒前
77完成签到,获得积分10
11秒前
眼睛大的小熊猫完成签到,获得积分10
11秒前
清爽难破完成签到 ,获得积分10
13秒前
13秒前
NingCp完成签到,获得积分10
14秒前
14秒前
15秒前
15秒前
15秒前
传奇3的应助被quantu采纳,获得10
15秒前
踏实以松发布了新的文献求助10
15秒前
丘比特的应助被幽凡采纳,获得10
17秒前
林林完成签到 ,获得积分10
18秒前
坚强孤容发布了新的文献求助10
20秒前
20秒前
21秒前
迷你的寄云完成签到,获得积分10
23秒前
23秒前
24秒前
李麟发布了新的文献求助10
24秒前
思源的应助被邵蹦蹦采纳,获得10
25秒前
26秒前
xuejingling发布了新的文献求助10
26秒前
molihuakai的应助被长情豁采纳,获得10
26秒前
科研通AI6.2的应助被123采纳,获得10
26秒前
哈哈客发布了新的文献求助10
28秒前
在水一方的应助被百里采纳,获得10
28秒前
搜集达人的应助被坚强孤容采纳,获得10
29秒前
30秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8186734
求助须知:如何正确求助?哪些是违规求助? 9575007
关于积分的说明 21839114
捐赠科研通 7784289
什么是DOI,文献DOI怎么找? 3434808
关于科研通互助平台的介绍 2559206
邀请新用户注册赠送积分活动 2481611